001540 — AHN-GOOK PHARMACEUTICAL Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapContrarian

Annual income statement for AHN-GOOK PHARMACEUTICAL Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS/A	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	—	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	163,534	205,389	233,676	271,116	306,874
Cost of Revenue
Gross Profit	101,018	126,279	140,571	167,896	200,302
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	164,618	196,221	228,679	264,634	297,050
Operating Profit	-1,084	9,167	4,997	6,482	9,824
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	3,805	7,375	4,267	20,239	7,717
Provision for Income Taxes
Net Income After Taxes	3,744	6,879	998	16,343	7,319
Minority Interest
Net Income Before Extraordinary Items
Net Income	3,939	6,875	1,290	16,845	7,481
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	3,939	6,875	1,290	16,845	7,481
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	332	644	116	559	654
Dividends per Share